What are the guidelines for deworming in children and adults, including recommended medications, dosages, and treatment duration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Deworming Guidelines for Children and Adults

Children: Recommended Approach

For routine preventive deworming in endemic areas, administer albendazole 400 mg as a single oral dose every 6 months to all children over 24 months of age, with treatment repeated at 8 weeks for schistosomiasis-endemic regions. 1

Dosing by Age Group

Children ≥24 months:

  • Albendazole 400 mg single dose OR Mebendazole 500 mg single dose for soil-transmitted helminths (ascariasis, hookworm, trichuriasis) 1, 2
  • For empirical treatment with suspected strongyloidiasis: Add ivermectin 200 μg/kg single dose (must exclude Loa loa exposure before ivermectin administration) 1
  • Repeat treatment at 8 weeks if schistosomiasis is suspected, as eggs and immature forms are resistant to initial treatment 1

Children 12-24 months:

  • Requires expert consultation before treatment 1
  • Standard albendazole 400 mg may be used but discuss with specialist first

Children <12 months:

  • Not routinely recommended in standard deworming programs 1

Treatment Duration by Infection Type

Single-dose therapy (most common):

  • Pinworm (Enterobius): 1 tablet once; repeat if not cured after 3 weeks 2
  • Ascariasis, Trichuriasis, Hookworm: Mebendazole 500 mg twice daily for 3 consecutive days 2
  • Schistosomiasis: Praziquantel 25 mg/kg three times daily for 2-3 consecutive days 1

Extended therapy (specific infections):

  • Cutaneous larva migrans: Albendazole 400 mg twice daily for 21 days 1
  • Echinococcosis: Requires specialist management 1
  • Fascioliasis: Triclabendazole 10 mg/kg once daily for 2 days 1

Critical Caveats for Pediatric Deworming

  • Take with food: Albendazole absorption increases up to 5-fold when administered with fatty meals (approximately 40 grams fat content) 3
  • Tablets may be crushed: For children unable to swallow whole tablets, crush and mix with food 2, 3
  • Geographic considerations: Must exclude Loa loa in children who traveled to endemic regions (Central/West Africa) before administering ivermectin to prevent severe adverse reactions 1
  • Treatment efficacy varies: Single-dose albendazole shows high cure rates for Ascaris (91-97%) but lower rates for Trichuris (27-51%) 4, 5, 6

When Triple-Dose Regimens Are Warranted

For persistent Trichuris trichiura infections:

  • Albendazole 400 mg daily for 3 consecutive days achieves 92% cure rate versus 69% with single dose 4
  • Mebendazole 500 mg daily for 3 consecutive days achieves 71% cure rate versus 29% with single dose 4
  • Alternative for treatment failures: Albendazole 400 mg plus ivermectin 600 μg single doses combined achieves 75% cure rate for Trichuris 5

Adults: Recommended Approach

Adults should receive the same dosing as children for routine deworming: albendazole 400 mg single dose or mebendazole 500 mg single dose, with treatment frequency based on endemic risk. 1, 2

Standard Adult Dosing

Soil-transmitted helminths:

  • Albendazole 400 mg single dose OR Mebendazole 500 mg single dose OR Ivermectin 200 μg/kg single dose 1
  • Maximum daily dose: 4 grams amoxicillin equivalent (not applicable to albendazole/mebendazole which have fixed dosing) 7

Schistosomiasis:

  • Praziquantel 25 mg/kg three times daily for 2-3 consecutive days 1
  • Alternative: Praziquantel 40 mg/kg single dose for Schistosoma mansoni and S. haematobium 1

Tapeworm infections:

  • Praziquantel 40 mg/kg single dose for intestinal Taenia species 1
  • Praziquantel 60 mg/kg in two divided doses for other cestode infections 1

Fascioliasis:

  • Triclabendazole 10 mg/kg once daily for 2 days (note: increasing resistance reported) 1

Treatment Frequency

Endemic areas with >20% prevalence:

  • Biannual treatment (every 6 months) recommended by WHO for preventive chemotherapy programs 8, 9
  • Mexico's national program administers deworming approximately every 8 months through health weeks 9

Post-treatment monitoring:

  • Reassess 2-4 weeks after treatment for persistent infections 8, 5
  • If infection persists at 3 weeks, administer second course 2
  • For schistosomiasis, repeat at 8 weeks to treat residual worms that matured after initial treatment 1

Important Adult-Specific Considerations

  • Pregnancy: Albendazole is contraindicated; advise pregnant women of fetal risks 3
  • HIV infection: Same dosing applies, though helminth co-infection is common cause of eosinophilia in HIV-positive patients 1
  • Immunocompromised patients: Seek expert advice, particularly for strongyloidiasis which can cause hyperinfection syndrome 1

Common Pitfalls to Avoid

  1. Inadequate treatment of Trichuris: Single-dose therapy has only 27-51% cure rates; consider triple-dose regimens or combination therapy for moderate-to-heavy infections 4, 5, 6

  2. Forgetting repeat dosing for schistosomiasis: Immature forms resist treatment; 8-week repeat is essential 1

  3. Administering ivermectin without screening for Loa loa: Can cause fatal encephalopathy in co-infected patients 1

  4. Fasting administration: Significantly reduces albendazole absorption; always give with fatty meal 3

  5. Assuming single-dose cures all infections: Efficacy varies dramatically by species—Ascaris 93-97%, Trichuris 27-51%, hookworm 78-92% 4, 5, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.